LEI 969500LLLTSXOQGHDY93
APMONIA THERAPEUTICS
Contract awards & public grants
Novel peptide-based therapeutics for reprogramming the tumour stroma extracellular matrix using molecular modelling and computational engineering → APMONIA THERAPEUTICS
European Commission · FR · Grant · 2024-12-13
€2.43M
APMONIA THERAPEUTICS — INOTAX
Secrétariat Général Pour l'Investissement (SGPI) · FR · Grant · 2023-01-01
€2.22M
Entity identity is matched from published recipient names and registry IDs to GLEIF legal-entity records; matches can be imperfect. Source records are public procurement and grant notices.